CSJ speaks to UK-based Mediplus, a specialist in pelvic floor treatments, about incontinence in women, the associated risks with surgical mesh and how they can be eliminated by using non-surgical treatments.
Since 2014 the use of surgical mesh for prolapse involving the bladder or bowel has been withdrawn in Scotland and in England the National Institute for Health and Care Excellence (NICE) is currently reviewing its guidelines. This month, CSJ speaks to UK-based Mediplus, a specialist in pelvic floor treatments, about incontinence in women, the associated risks with surgical mesh and how they can be eliminated by using non-surgical treatments.
Urinary incontinence affects women of all ages. Varying in severity and nature, although the condition is not life threatening, it impacts physically, psychologically and socially on a person’s wellbeing, and on their families and carers. It is also closely linked to pelvic organ prolapse.
Up to 60% of women with pelvic organ prolapse are also diagnosed with urinary incontinence, and around 40% of women presenting with urinary incontinence are found to have some degree of pelvic organ prolapse.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
